CBD, Genetics, Pediatric Epilepsy
A round-up of key epilepsy research news from the past month.
Treatment with valproic acid is unavoidable in many women with epilepsy of childbearing age despite recent regulations.
Persons with dementia are also at higher risk of having recurring seizures and of experiencing seizures for the first time at a younger age, compared to people without dementia.
Genetics
Researchers identified a set of neurons in the brain as critical targets for therapeutic intervention, utilizing a mouse model mimicking a mutation of the sodium channel gene SCN8A found in 14 individuals with epilepsy.
The new treatment offers a new therapeutic strategy for patients whose epilepsy cannot be treated effectively by medications or resective surgery.
In a large cohort of patients, researchers analyzed the longitudinal outcomes and predictors of seizure outcomes after frontal lobe epilepsy (FLE) surgery, the second most common focal resective surgery for drug-resistant epilepsy.
Pediatric Epilepsy
Onset in infancy and developmental delay is associated with an especially high risk, regardless of epilepsy type.
Pediatric Epilepsy
Treatment was found to be effective in more than half of the children diagnosed with generalized epilepsy and focal epilepsy.
A type of cell in the brain called “atypical astrocyte” may increase following trauma, causing epilepsy following repeated, mild TBI, according to a study by Dr. Oleskii Shandra and Dr. Stefanie Robel.